Monitoring the prevalence and antibiotic resistance of Klebsiella pneumoniae strains in a multidisciplinary hospital
https://doi.org/10.25789/YMJ.2024.88.14
Abstract
The study evaluated the prevalence and resistance of Klebsiella pneumoniae strains to antibacterial drugs. This study included 4580 Klebsiella pneumoniae strains isolated from patients of the Republican Hospital No. 2 - Emergency Medical Care Center in the period from 2016 to 2022. The analysis showed that the majority of Klebsiella pneumoniae strains detected in intensive care and surgical departments. The dynamics show an increase in the prevalence of Klebsiella pneumoniae strains and an increase in resistance to carbapenems, against the background of a high proportion of isolates producing extended-spectrum β-lactamases.
About the Authors
A. A. Kuzmina
ФГАОУ ВО «Северо-Восточный федеральный университет им. М.К. Аммосова»
Russian Federation
Russian Federation
T. M. Klimova
Медицинского института ФГАОУ ВО «Северо-Восточный федеральный университет им. М.К. Аммосова»; ФГБНУ «ЯНЦ
КМП»
Russian Federation
Russian Federation
S. Kh. Shamaeva
ГБУ РС(Я) «Республиканская больница № 2 – Центр экстренной медицинской помощи»
Russian Federation
Russian Federation
A. F. Potapov
Медицинский институт ФГАОУ ВО «Северо-Восточный
федеральный университет им. М.К. Аммосова
Russian Federation
Russian Federation
E. A. Bushkova
Медицинский институт ФГАОУ ВО «Северо-Восточный федеральный университет им. М.К. Аммосова»
Russian Federation
Russian Federation
I. Sh. Malogulova
Медицинский институт ФГАОУ ВО «Северо-Восточный федеральный университет им. М.К. Аммосова»
Russian Federation
Russian Federation
References
1. Antimicrobial resistance of Gramnegative pathogens of nosocomial pneumonia in intensive care unit patients / Pervukhin S.A. [et al.] // Clinical Microbiology and Antimicrobial Chemotherapy. 2019. vol. 21. No. 1. Р. 62–68. doi: 10.36488/cmac.2019.1.62-68.
2. Antibiotic resistance – a new challenge of modern urology / Kotov S.V. [et al.] // Experimental and Clinical Urology 2020.13(5). Р.113-119. Doi:10.29188/2222-8543-2020-13-5-113-119.
3. Antimicrobial resistance of nosocomial enterobacterales isolates in Russia: results of multicenter epidemiological study "Marathon 2015- 2016" / Sukhorukova M.V. [et al.] // Clinical Microbiology and Antimicrobial Chemotherapy. 2019. 21(2). P. 147-159.
4. Antimicrobial resistance of nosocomial enterobacteriaceae isolates in Russia: results of multicenter epidemiological study "Marathon" 2013-2014 / Sukhorukova M.V. et al. // Clinical Microbiology and Antimicrobial Chemotherapy. 2017. 19(1). P.49-56.
5. Characterization of genetic diversity of the Klebsiella pneumoniae strains in a Moscow tertiary care center using next-generation sequencing / Skachkova T.S. [et al.] // Clinical Microbiology and Antimicrobial Chemotherapy. 2019. Vol. 21. No. 1. P. 69–74. doi: 10.36488/cmac.2019.1.69-74.
6. Kozlova N.S., Barantsevich N.E., Barantsevich E.P. Susceptibility to antibiotics in Klebsiella pneumoniae strains isolated in a multidisciplinary medical centre// Russian Journal of Infection and Immunity. 2018. Vol. 8. No. 1. Р. 79–84. doi: 10.15789/2220-7619-2018-1-79-84.
7. Experience in implementing the AMRcloud online platform for local antimicrobial resistance surveillance in a tertiary care hospital / L.V. Petrova [et al.] // Clinical Microbiology and Antimicrobial Chemotherapy 2022. 24(1). P.39-46.
8. Antimicrobial resistance and antimicrobial therapy modification during COVID-19 pandemic in a large tertiary hospital / Romashov O.M. [et al.] //Clinical Microbiology and Antimicrobial Chemotherapy. 2021. 23(3). P.293-303.
9. Susceptibility of clinical Enterobacterales and Pseudomonas aeruginosa isolates to ceftazidime-avibactam in Russia: multicenter local laboratory data-based surveillance / М.V. Edelstein [et al.] // Clinical Microbiology and Antimicrobial Chemotherapy. 2021. 23(3). P.264-278.
10. The reasons why Klebsiella pneumoniae becomes a leading opportunistic pathogen / Chebotar I.V. [et al.] // Clinical Microbiology and Antimicrobial Chemotherapy. 2020.22(1). P.4-19. DOI 10.36488/cmac.2020.1.4-19.
11. Tapalsky D.V., Petrenev D.R. Prevalence of carbapenemase-producing klebsiella pneumoniae isolates in Belarus and their competitive ability// Clinical Microbiology and Antimicrobial Chemotherapy. 2017. 19(2). P.139-144.
12. Resistance factors of Klebsiella pneumoniae bacteria during COVID-19 pandemic /Kolotova O.N. [et al.] // Russian Journal of Infection and Immunity. 2022. Vol. 12. no. 3. Р. 563–568. doi: 10.15789/2220-7619-RFO-1837
Review
For citations:
Kuzmina A.A., Klimova T.M., Shamaeva S.Kh., Potapov A.F., Bushkova E.A., Malogulova I.Sh. Monitoring the prevalence and antibiotic resistance of Klebsiella pneumoniae strains in a multidisciplinary hospital. Yakut Medical Journal. 2024;(4):60-63. (In Russ.) https://doi.org/10.25789/YMJ.2024.88.14
Views:
25
Email this article 